These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1534582)

  • 21. Effects of antihypertensive therapy on hypertensive heart disease.
    Messerli FH; Kaesser UR; Losem CJ
    Circulation; 1989 Dec; 80(6 Suppl):IV145-50. PubMed ID: 2532079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Echocardiographic studies of regression of left ventricular hypertrophy in hypertension.
    Fouad-Tarazi FM; Liebson PR
    Hypertension; 1987 Feb; 9(2 Pt 2):II65-8. PubMed ID: 2948912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Echocardiography in clinical pharmacology: developing new concepts on the pathophysiology of left ventricular hypertrophy in arterial hypertension.
    Corea L; Bentivoglio M; Verdecchia P; Motolese M
    Int J Clin Pharmacol Res; 1983; 3(3):157-61. PubMed ID: 6237069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment.
    Novo S; Abrignani MG; Corda M; Strano A
    Eur Heart J; 1991 Dec; 12 Suppl G():47-52. PubMed ID: 1839619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular hypertrophy and antihypertensive therapy.
    Graettinger WF; Weber MA
    Am Fam Physician; 1992 Aug; 46(2):483-91. PubMed ID: 1386180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carteolol, an antihypertensive beta-blocker with intrinsic sympathomimetic activity, reduces ECG evidence of left ventricular hypertrophy.
    Rosales OR; Sander GE; Roffidal L; Given MB; Giles TD
    Chest; 1989 Jan; 95(1):43-7. PubMed ID: 2521204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Electrocardiographic and echocardiographic changes during antihypertensive therapy].
    Sau F; Seguro C; Pili G; Basciu M; Siddi PP; Tamponi R; Cherchi A
    Cardiologia; 1990 Dec; 35(12):1015-22. PubMed ID: 2151370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.
    Rodilla E; Pascual JM; Costa JA; Martin J; Gonzalez C; Redon J
    J Hypertens; 2013 Aug; 31(8):1683-91. PubMed ID: 23835910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive treatment is associated with improved left ventricular geometry: the Rotterdam Study.
    Bleumink GS; Deinum J; Mosterd A; Witteman JC; Hofman A; Stricker BH
    Pharmacoepidemiol Drug Saf; 2004 Oct; 13(10):703-9. PubMed ID: 15386731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients.
    Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ
    Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of cardiac hypertrophy in humans.
    Tarazi RC; Fouad FM
    Hypertension; 1984; 6(6 Pt 2):III140-6. PubMed ID: 6240447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive therapy in diabetic patients.
    Weidmann P; Boehlen LM; de Courten M; Ferrari P
    J Hum Hypertens; 1992 Dec; 6 Suppl 2():S23-36. PubMed ID: 1289510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart and vessel hypertrophy in hypertension: possibilities of regression.
    Cífková R; Niederle P; Romanovská L; Skibová J; Frídl P; Skalická H; Widimský J
    J Hypertens Suppl; 1987 Dec; 5(5):S407-10. PubMed ID: 2965227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.